Admission Date:  [**2166-9-26**]              Discharge Date:   [**2166-10-1**]  Date of Birth:  [**2104-2-5**]             Sex:   F  Service: MEDICINE  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**First Name3 (LF) 896**] Chief Complaint: Abdominal pain  Major Surgical or Invasive Procedure: Paracentesis ([**2166-9-27**]) ERCP wtih stone fragmente extraction and placement of an 11cm by 10FR Cotton-[**Doctor Last Name **] biliary stent ([**2166-9-28**])   History of Present Illness: 62F with known metastatic pancreatic cancer, notably to the liver causing biliary obstruction s/p ERCP with stent placement [**2166-7-25**] to the left hepatic biliary tree with no opacification of the right biliary tree presenting with increasing abdominal distension and pain with nausea and non-bloody loose stool over the last week.
Prior to that, she had had anorexia since her diagnosis in [**Month (only) **], slightly improved with stent placement in [**Month (only) 205**], significantly worse for the last few days.
At baseline, she walks around her home with a cane but has been unable to do so this week.
Hepatology, ERCP, and surgery were all consulted in the ED.
She also was tachypneic in the ED to 35, was given Combivent nebs with improvement in wheezes but no improvement in tachypnea.
She appeared to be tiring out and moving toward intubation and so therapeutic paracentesis was performed with removal of 1.5L and immediate resolution of tachypnea.
She was given Ceftriaxone 1 gram, Levofloxacin 750mg IV, Zosyn 4.5 grams, Combivent nebs x2, Tylenol 650mg PR for fever 101 rectally, albumin 5% 12.5 grams.
Denies chest pain, chest pressure, palpitations, or weakness.
Pancreatic cancer    - Diagnosed [**2166-6-4**]    - Metastatic to liver    - Treatment has included palliative chemo 2.
Physical Exam: Admission Exam: Vitals: T: 97.5 BP: 118/70 P: 121 R: 27 O2: 98%RA General: Alert, oriented, chronically ill appearing HEENT: Sclera mildly icteric, MM dry, oropharynx clear, moderate dentition Neck: supple, JVP not elevated, no LAD Lungs: DIffuse very coarse BS on L, scattered wheezes on R with moderate air entry, no crackles CV: Fast but regular, normal S1 + S2, no murmurs, rubs, gallops  Abdomen: soft, distended, diffuse mild TTP, most pronounced in epigastric region, bowel sounds present, no rebound tenderness or guarding, no organomegaly appreciated GU: foley in place Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema  Pertinent Discharge Exam: Abdomen soft with mild distention; not tense; very minimally tender in upper quadrants Skin jaundiced  Pertinent Results: ADMISSION [**2166-9-26**] WBC-27.0*# RBC-3.78* HGB-10.7* HCT-31.9* MCV-84 MCH-28.3 MCHC-33.5 RDW-16.3* NEUTS-95.9* LYMPHS-2.0* MONOS-1.3* EOS-0.6 BASOS-0.1 ALT(SGPT)-74* AST(SGOT)-149* LD(LDH)-243 ALK PHOS-674* AMYLASE-103* TOT BILI-4.0* DIR BILI-3.3* INDIR BIL-0.7 GLUCOSE-142* UREA N-12 CREAT-0.8 SODIUM-134 POTASSIUM-3.5 CHLORIDE-104 TOTAL CO2-19* ANION GAP-15 LACTATE-1.9  DISCHARGE: [**2166-10-1**] BLOOD WBC-11.9* RBC-4.37 Hgb-12.7 Hct-37.1 MCV-85 MCH-29.1 MCHC-34.3 RDW-16.5* Plt Ct-242 Glucose-126* UreaN-11 Creat-0.9 Na-132* K-3.2* Cl-96 HCO3-21* AnGap-18 ALT-45* AST-74* AlkPhos-405* TotBili-4.5* BLOOD Albumin-3.1* Calcium-9.1 Phos-2.1* Mg-1.8  ASCITES  WBC-306* RBC-628* POLYS-25* LYMPHS-41* MONOS-0 MESOTHELI-1* MACROPHAG-33* ASCITES  TOT PROT-2.6 GLUCOSE-140 LD(LDH)-70 ALBUMIN-1.3  Peritoneal fluid cytology: POSITIVE FOR MALIGNANT CELLS.
CBD stent in place with pneumobilia and no intrahepatic biliary ductal dilatation in the right lobe; known left lobe biliary dilatation not well appreciated on this study.
Treated with pip-tazo with vancomycin initially.
Cultures remained negative and given likely biliary source, plan was to complete 10 day course with ciprofloxacin and metronidazole.
Pancreatic cancer, complicated by:    - Liver metastases    - Biliary obstruction    - Malignant ascites Underwent diagnostic and therapeutic paracentesis with removal of 1.5 liters; fluid was positive for malignant cells.
Underwent ERCP with placement of plastic stent inside prior metal stent; stent obstruction from tumor ingrowth was noted.
Two stone fragments were extracted using a balloon.
Sliding scale insulin was used while in patient.
Medications on Admission: metoclopramide 10 mg Tab Tablet(s) by mouth prochlorperazine maleate 10 mg Tablet(s) by mouth once a day glipizide 10 mg Tab Tablet(s) by mouth twice a day dronabinol 10 mg Cap Capsule(s) by mouth once a day oxycodone 5 mg Tab Tablet(s) by mouth four times a day metformin 1,000 mg Tab Tablet(s) by mouth twice a day ondansetron HCl 4 mg Tab Tablet(s) by mouth once a day pantoprazole 40 mg Tab, Delayed Release Oral Once Daily Singulair 10 mg Tab Oral 1 Tablet(s) Once Daily ProAir HFA 90 mcg Inhaler 1 HFA Aerosol Inhaler(s), as needed megestrol acetate 40mg/mL daily  Discharge Medications: 1. glipizide 10 mg Tablet Sig: One (1) Tablet PO twice a day.
2. metformin 1,000 mg Tablet Sig: One (1) Tablet PO twice a day.
3. ondansetron 4 mg Film Sig: One (1)  PO twice a day as needed for nausea.
5. montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
ProAir HFA 90 mcg/Actuation HFA Aerosol Inhaler Sig: [**1-5**] Inhalation every six (6) hours as needed for shortness of breath or wheezing.
7. oxycodone 5 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed for pain.
Disp:*20 Tablet(s)* Refills:*0* 8. ciprofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours) for 4 days.
Disp:*8 Tablet(s)* Refills:*0* 9. metronidazole 500 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours) for 4 days.
Disp:*12 Tablet(s)* Refills:*0* 10. megestrol 40 mg Tablet Sig: One (1) Tablet PO once a day.
SIRS/sepsis with cholangitis 2.
After treatment with antibiotics and a stent placement in bile duct there was improvement.
